Unlocking tumor genomics in saliva to detect and diagnose cancer.
Head and Neck Cancers are 6th Most Common
Yet, over 60% cases are detected late and late-stage oral cancer detection has surged more than 1.5X in the last two decades.
OrisDX detects more than 93% of oral cancers
“The test is non-invasive, not painful, easy to do, quick results, tests are accurate. If a lesion in your mouth needs to be checked, I trust OrisDX. ”
-
Our multiomic salivary diagnostic platform uses non-invasive saliva samples and next-generation sequencing + proprietary algorithms to rapidly and accurately detect genetic biomarkers, setting a new standard in precision diagnostics.
-
Our vision is to revolutionize healthcare with non-invasive salivary diagnostics, enabling swift, accurate detection of disease through advanced molecular analysis, enhancing lives with early, proactive intervention.